Somaxon Pharmaceuticals Inc. v. Par Pharmaceutical Inc. (1:11-cv-00476)
District Court, D. Delaware
Document Number
1
May 26, 2011
COMPLAINT filed against Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-894613.) - filed by Somaxon Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(lid) (Entered: 05/27/2011)
Main Doc
Complaint
Att 1
Exhibit A
Att 2
Civil Cover Sheet
2
May 26, 2011
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (lid) (Entered: 05/27/2011)
Main Doc
Magistrate Consent Forms
3
May 26, 2011
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/23/2010. Date of Expiration of Patent: 8/24/2027.Thirty Month Stay Deadline: 6/23/2013. (lid) (Entered: 05/27/2011)
Main Doc
ANDA Form
4
May 26, 2011
Disclosure Statement pursuant to Rule 7.1 filed by Somaxon Pharmaceuticals Inc.. (lid) (Entered: 05/27/2011)
Main Doc
Disclosure Statement
5
May 26, 2011
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,915,307. (lid) (Entered: 05/27/2011)
Main Doc
Patent/Trademark Report to Commissioner
6
Jun 3, 2011
STIPULATION AND ORDER (regarding consolidation) by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc., Somaxon Pharmaceuticals Inc., Procom One Inc.. (Noreika, Maryellen) (Entered: 06/03/2011)
Stipulation